Position history for Woodline Partners LP's holdings in PROTAGONIST THERAPEUTICS INC
Woodline Partners LP holds 1.4M shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $123M as of 2025-Q4. The position was decreased (-2.0% shares). PTGX represents 0.5% of Woodline Partners LP's portfolio.
Current Value
$123M
Current Shares
1.4M
Total Value Change
+$94.6M
Total Shares Change
+586,599
Other major holders of PTGX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, CAPITAL FUND MANAGEMENT S.A.
Decreased |
| 1.4M |
-2.0% |
| $123M |
| 0.5% |
| $87.26 |
0 |
| 2025-Q3 | Increased | 1.4M | +51.9% | $95.5M | 0.4% | $65.14 | 50 |
| 2025-Q2 | Increased | 946,884 | +5.5% | $52.3M | 0.3% | $55.69 | 37 |
| 2025-Q1 | Increased | 897,699 | +54.2% | $43.4M | 0.3% | $48.88 | 49 |
| 2024-Q4 | Increased | 582,327 | +24.8% | $22.5M | 0.2% | $38.51 | 42 |
| 2024-Q3 | Decreased | 466,518 | -43.3% | $21M | 0.2% | $44.56 | 0 |
| 2024-Q2 | Increased | 822,173 | +29.1% | $28.5M | 0.3% | $34.65 | 43 |